BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

530 related articles for article (PubMed ID: 32861749)

  • 1. Early life exposure to per- and polyfluoroalkyl substances (PFAS) and latent health outcomes: A review including the placenta as a target tissue and possible driver of peri- and postnatal effects.
    Blake BE; Fenton SE
    Toxicology; 2020 Oct; 443():152565. PubMed ID: 32861749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Considering environmental exposures to per- and polyfluoroalkyl substances (PFAS) as risk factors for hypertensive disorders of pregnancy.
    Erinc A; Davis MB; Padmanabhan V; Langen E; Goodrich JM
    Environ Res; 2021 Jun; 197():111113. PubMed ID: 33823190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating maternal exposure to an environmental per and polyfluoroalkyl substances (PFAS) mixture during pregnancy: Adverse maternal and fetoplacental effects in a New Zealand White (NZW) rabbit model.
    Crute CE; Hall SM; Landon CD; Garner A; Everitt JI; Zhang S; Blake B; Olofsson D; Chen H; Murphy SK; Stapleton HM; Feng L
    Sci Total Environ; 2022 Sep; 838(Pt 4):156499. PubMed ID: 35679923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concentrations of per- and polyfluoroalkyl substances (PFAS) in human placental tissues and associations with birth outcomes.
    Hall SM; Zhang S; Hoffman K; Miranda ML; Stapleton HM
    Chemosphere; 2022 May; 295():133873. PubMed ID: 35143854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations of paternal and maternal per- and polyfluoroalkyl substances exposure with cord serum reproductive hormones, placental steroidogenic enzyme and birth weight.
    Yao Q; Gao Y; Zhang Y; Qin K; Liew Z; Tian Y
    Chemosphere; 2021 Dec; 285():131521. PubMed ID: 34273704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prenatal exposure to per- and polyfluoroalkyl substances and pregnancy outcome in Austria.
    Kaiser AM; Forsthuber M; Widhalm R; Granitzer S; Weiss S; Zeisler H; Foessleitner P; Salzer H; Grasl-Kraupp B; Moshammer H; Hartmann C; Uhl M; Gundacker C
    Ecotoxicol Environ Saf; 2023 Jul; 259():115006. PubMed ID: 37182303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations of Maternal Stress, Prenatal Exposure to Per- and Polyfluoroalkyl Substances (PFAS), and Demographic Risk Factors with Birth Outcomes and Offspring Neurodevelopment: An Overview of the ECHO.CA.IL Prospective Birth Cohorts.
    Eick SM; Enright EA; Geiger SD; Dzwilewski KLC; DeMicco E; Smith S; Park JS; Aguiar A; Woodruff TJ; Morello-Frosch R; Schantz SL
    Int J Environ Res Public Health; 2021 Jan; 18(2):. PubMed ID: 33467168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prenatal and perinatal exposure to Per- and polyfluoroalkyl substances (PFAS)-contaminated drinking water impacts offspring neurobehavior and development.
    Marchese MJ; Zhu T; Hawkey AB; Wang K; Yuan E; Wen J; Be SE; Levin ED; Feng L
    Sci Total Environ; 2024 Mar; 917():170459. PubMed ID: 38290673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mixture effects of prenatal exposure to per- and polyfluoroalkyl substances and polybrominated diphenyl ethers on maternal and newborn telomere length.
    Eick SM; Goin DE; Cushing L; DeMicco E; Park JS; Wang Y; Smith S; Padula AM; Woodruff TJ; Morello-Frosch R
    Environ Health; 2021 Jun; 20(1):76. PubMed ID: 34193151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prenatal exposure to per-and polyfluoroalkyl substances and child executive function: Evidence from the Shanghai birth cohort study.
    Yang X; Zheng L; Zhang J; Wang H
    Environ Int; 2024 Jan; 183():108437. PubMed ID: 38232503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic Perturbations Associated with an Exposure Mixture of Per- and Polyfluoroalkyl Substances in the Atlanta African American Maternal-Child Cohort.
    Liang D; Taibl KR; Dunlop AL; Barr DB; Ryan PB; Everson T; Huels A; Tan Y; Panuwet P; Kannan K; Marsit C; Jones DP; Eick SM
    Environ Sci Technol; 2023 Oct; 57(43):16206-16218. PubMed ID: 37857362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prenatal exposure to per- and polyfluoroalkyl substances (PFAS) and associations with attention-deficit/hyperactivity disorder and autism spectrum disorder in children.
    Skogheim TS; Weyde KVF; Aase H; Engel SM; Surén P; Øie MG; Biele G; Reichborn-Kjennerud T; Brantsæter AL; Haug LS; Sabaredzovic A; Auyeung B; Villanger GD
    Environ Res; 2021 Nov; 202():111692. PubMed ID: 34293314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perfluoroalkyl and polyfluoroalkyl substances and hypertensive disorders of pregnancy: A systematic review and meta-analysis.
    Hu CY; Qiao JC; Gui SY; Xu KX; Dzhambov AM; Zhang XJ
    Environ Res; 2023 Aug; 231(Pt 2):116064. PubMed ID: 37178750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of maternal high fat diet on mouse pup metabolic endpoints following perinatal PFAS and PFAS mixture exposure.
    Marques ES; Agudelo J; Kaye EM; Modaresi SMS; Pfohl M; Bečanová J; Wei W; Polunas M; Goedken M; Slitt AL
    Toxicology; 2021 Oct; 462():152921. PubMed ID: 34464680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PFAS alters placental arterial vasculature in term human placentae: A prospective pregnancy cohort study.
    Chowdhury SF; Prout N; Rivera-Núñez Z; Barrett E; Brunner J; Duberstein Z; Kannan K; Salafia CM; Shah R; Miller RK; O'Connor TG
    Placenta; 2024 Apr; 149():54-63. PubMed ID: 38518389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identifying Risk Factors for Levels of Per- and Polyfluoroalkyl Substances (PFAS) in the Placenta in a High-Risk Pregnancy Cohort in North Carolina.
    Bangma J; Eaves LA; Oldenburg K; Reiner JL; Manuck T; Fry RC
    Environ Sci Technol; 2020 Jul; 54(13):8158-8166. PubMed ID: 32469207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prenatal per- and polyfluoroalkyl substances (PFAS) exposure in relation to preterm birth subtypes and size-for-gestational age in the LIFECODES cohort 2006-2008.
    Siwakoti RC; Cathey A; Ferguson KK; Hao W; Cantonwine DE; Mukherjee B; McElrath TF; Meeker JD
    Environ Res; 2023 Nov; 237(Pt 2):116967. PubMed ID: 37634691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prenatal exposure to per- and polyfluoroalkyl substances and maternal and neonatal thyroid function in the Project Viva Cohort: A mixtures approach.
    Preston EV; Webster TF; Claus Henn B; McClean MD; Gennings C; Oken E; Rifas-Shiman SL; Pearce EN; Calafat AM; Fleisch AF; Sagiv SK
    Environ Int; 2020 Jun; 139():105728. PubMed ID: 32311629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perfluoroalkyl Substances (PFAS) and Their Effects on the Placenta, Pregnancy, and Child Development: a Potential Mechanistic Role for Placental Peroxisome Proliferator-Activated Receptors (PPARs).
    Szilagyi JT; Avula V; Fry RC
    Curr Environ Health Rep; 2020 Sep; 7(3):222-230. PubMed ID: 32812200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prenatal exposure to per- and polyfluoroalkyl substances and infant sleep disturbance: A prospective cohort study.
    Huang Y; Fang F; Chen Y; He X; Chen Q; Wang H; Zhang J;
    Environ Int; 2023 Aug; 178():108070. PubMed ID: 37399769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.